Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Expands By 10.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 3,200 shares, an increase of 10.3% from the December 31st total of 2,900 shares. Based on an average daily trading volume, of 154,200 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Trading Down 4.0 %

Shares of NASDAQ BCTXW traded down $0.01 during mid-day trading on Monday, reaching $0.16. The company had a trading volume of 353,791 shares, compared to its average volume of 117,700. BriaCell Therapeutics has a 52-week low of $0.11 and a 52-week high of $1.89. The firm has a 50 day simple moving average of $0.28 and a two-hundred day simple moving average of $0.27.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.